NCT00582582View on ClinicalTrials.gov

Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

April 30, 2007

Conditions
Prostate Cancer
Interventions
DRUG

Docetaxel plus doxercalciferol

Docetaxel 35mg/m2 IV weekly x3 every 4 weeks plus Doxercalciferol 10mcg orally every day

DRUG

Docetaxel plus placebo

Docetaxel 35mg/m2 IV weekly x3 every 4 week cycle plus placebo taken orally every day

Trial Locations (1)

53792-5669

University of Wisconsin, Madison

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

University of Wisconsin, Madison

OTHER